Inventor
NIXON ANDREW
US23 patents
⚠️ This page may combine multiple inventors who share the name “NIXON ANDREW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA PHARMACEUTICALS CO
10 patentsUS11372002B2Jun 28, 2022
Assays for determining plasma kallikrein system biomarkers
TAKEDA PHARMACEUTICALS CO9 citations84
US11299553B2Apr 12, 2022
Anti-plasma kallikrein antibodies
TAKEDA PHARMACEUTICALS CO8 citations83
US12084515B2Sep 10, 2024
Compositions and methods for treatment of diabetic macular edema
TAKEDA PHARMACEUTICALS CO4 citations74
US12061206B2Aug 13, 2024
Diagnosis and treatment of autoimmune diseases
TAKEDA PHARMACEUTICALS CO3 citations74
US12110343B2Oct 8, 2024
Anti-plasma kallikrein antibodies
TAKEDA PHARMACEUTICALS CO4 citations72
US11156612B2Oct 26, 2021
Methods of determining levels of cleaved and/or intact kininogen
TAKEDA PHARMACEUTICALS CO6 citations71
US11390687B2Jul 19, 2022
Bispecific antibodies against plasma kallikrein and Factor XII
TAKEDA PHARMACEUTICALS CO3 citations67
US12442824B2Oct 14, 2025
Assays for determining plasma kallikrein system biomarkers
TAKEDA PHARMACEUTICALS CO0 citations61
US12415866B2Sep 16, 2025
Monoclonal antibody inhibitor of Factor XIIa
TAKEDA PHARMACEUTICALS CO0 citations60
US12240918B2Mar 4, 2025
Bispecific antibodies against plasma kallikrein and factor XII
TAKEDA PHARMACEUTICALS CO0 citations56
DYAX CORP
8 patentsUS7329737B2Feb 12, 2008
Antibodies that bind hK-1
DYAX CORP54 citations94
US10428158B2Oct 1, 2019
Compositions and methods for treatment of diabetic macular edema
DYAX CORP14 citations93
US11046785B2Jun 29, 2021
Compositions and methods for treatment of diabetic macular edema
DYAX CORP11 citations85
US7273610B2Sep 25, 2007
Endotheliase-2 ligands
DYAX CORP14 citations84
US10648990B2May 12, 2020
Diagnosis and treatment of autoimmune diseases
DYAX CORP7 citations83
US10101344B2Oct 16, 2018
Diagnosis and treatment of autoimmune diseases
DYAX CORP8 citations83
US7993646B2Aug 9, 2011
HK1-binding proteins
DYAX CORP11 citations82
US10913802B2Feb 9, 2021
Monoclonal antibody inhibitor of factor XIIA
DYAX CORP3 citations71